Letter: Extending the Measurement of Inflammatory Bowel Disease Severity to Include Patient Important Outcomes-Authors' Reply

Aliment Pharmacol Ther. 2025 Jan;61(2):408-409. doi: 10.1111/apt.18421. Epub 2024 Nov 29.
No abstract available

Publication types

  • Letter